OrganoBalance GmbH

Develops, produces, and markets medicines used in the treatment of dental and skin bacterial infections.

Launch date

2001

Company register number HRB 82025 B (Charlottenburg (Berlin))

Berlin Germany (HQ)

Date	Investors	Amount	Round
Sep 2016	Novozymes	N/A	Acquisition
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about OrganoBalance GmbH